Merck's $800 Million Investment In Singapore Aims To Produce Returns Elsewhere
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - Merck & Co. Inc. has committed to manufacturing and research investments in Singapore totaling more than $800 million to meet the ever increasing demand in nearby emerging markets